Delivering extraordinary. Empowering ordinary.
We’re developing novel oral medicines for rare diseases to help patients take part in the everyday activities they enjoy.
Learn MoreStructure-guided Drug Design
We combine traditional cell biology with medicinal chemistry to build synthetic compounds that bind to specific protein targets to fight disease.
See Our ScienceBuilding a Rare Disease Drug Portfolio
We are developing a pipeline of oral drugs for rare diseases.
View Our PipelineRecent News
Stay up to date with the latest discoveries, events, and reports from BioCryst.
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
BioCryst Presents New Long-term and Real-world Data Demonstrating Sustained Reductions in Hereditary Angioedema Attack Rates and Improvement in Quality of Life with ORLADEYO® (berotralstat)
-
BioCryst to Present at Upcoming Investor Conferences
Join Our Team
We are a collection of passionate individuals united by a commitment to scientific excellence and an unwavering focus on the needs of patients.
JOB OPENINGS